US2007142641A1PendingUtilityA1

Atazanavir conjugates and antibodies useful in immunoassay

Assignee: ROCHE DIAGNOSTICS OPERATIONSPriority: Jul 13, 2001Filed: Dec 22, 2006Published: Jun 21, 2007
Est. expiryJul 13, 2021(expired)· nominal 20-yr term from priority
C07K 16/38C07K 16/44C07D 213/42
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Activated haptens useful for generating immunogens to the HIV protease inhibitor atazanavir, immunogens useful for producing antibodies to atazanavir, and antibodies and labeled conjugates useful in immunoassays for determination of atazanavir. The haptens feature an activated functionality at the central, non-terminal hydroxyl group.

Claims

exact text as granted — not AI-modified
1 . A compound having the structure  
     
       
         
         
             
             
         
       
     
     wherein Y is O, m is 0, L is a linker comprising 0 carbon atoms, and A is an activated ester.  
   
   
       2 . A compound having the structure  
     
       
         
         
             
             
         
       
     
     wherein Y is O, S, or NH, m is 1, L is a linker comprising from 1 to 40 carbon atoms arranged in a straight chain or a branched chain, saturated or unsaturated, an containing up to two ring structures and 0-20 heteroatoms, with the proviso that not more than two heteroatoms may be linked in sequence, and A is an activated ester.

Join the waitlist — get patent alerts

Track US2007142641A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.